Evaluation of Outcomes With Umbilical Cord Allograft for Musculoskeletal Conditions Musculoskeletal Conditions

ConditionsOsteoarthritis Tendinitis Sports Injury Degenerative Disc Disease Degenerative Arthritis Ligament Injury Neuropathy Pelvic Pain

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18+

SponsorR3 Stem Cell

About this trial

The aim of the study is to determine the efficacy of an Amniotic Fluid Tissue Product for pain relief and functional improvements for all types of musculoskeletal conditions. The study is prospective, with outcome measures being obtained at numerous time points after the regenerative procedure.

Eligibility criteria

Qualifiers

Age 18 and over.

Ability to attend follow up visits or at least converse on phone or complete email follow up forms.

Disqualifiers

Active Infection

Pregnancy, Lactating

Clotting disorder

Trial design

Treatments tested in this trial

Umbilical Allograft

Treatment groups

200 Participants

are divided into 1 treatment group

Sponsors and collaborators

R3 Stem Cell

Lead sponsor

Source ClinicalTrials.gov